Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
In the latest session, Bicara Therapeutics Inc (NASDAQ: BCAX) closed at $15.25 down -3.17% from its previous closing price of $15.75. In other words, the price has decreased by -$3.17 from its previous closing price. On the day, 0.22 million shares were traded. BCAX stock price reached its highest trading level at $15.975 during the session, while it also had its lowest trading level at $15.15.
Ratios:
For a deeper understanding of Bicara Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 36.01 and its Current Ratio is at 36.01. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on December 06, 2024, initiated with a Buy rating and assigned the stock a target price of $42.
On November 05, 2024, Rodman & Renshaw started tracking the stock assigning a Buy rating and target price of $48.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Sep 16 ’24 when RA CAPITAL MANAGEMENT, L.P. bought 1,833,000 shares for $18.00 per share. The transaction valued at 32,994,000 led to the insider holds 4,303,418 shares of the business.
Flynn James E bought 70,000 shares of BCAX for $1,260,000 on Sep 17 ’24. The Possible Members of 10% Group now owns 897,587 shares after completing the transaction at $18.00 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BCAX now has a Market Capitalization of 829837888 and an Enterprise Value of 309435040.
Stock Price History:
Over the past 52 weeks, BCAX has reached a high of $28.09, while it has fallen to a 52-week low of $15.44. The 50-Day Moving Average of the stock is -23.33%, while the 200-Day Moving Average is calculated to be -28.10%.
Shares Statistics:
For the past three months, BCAX has traded an average of 431.82K shares per day and 311050 over the past ten days. A total of 54.41M shares are outstanding, with a floating share count of 32.54M. Insiders hold about 40.20% of the company’s shares, while institutions hold 45.40% stake in the company. Shares short for BCAX as of 1734048000 were 3028320 with a Short Ratio of 7.01, compared to 1731628800 on 2072645.
Earnings Estimates
Its stock is currently analyzed by 3 different market analysts. The consensus estimate for the next quarter is -$0.38, with high estimates of -$0.38 and low estimates of -$0.38.
Analysts are recommending an EPS of between -$1.69 and -$3.85 for the fiscal current year, implying an average EPS of -$2.74. EPS for the following year is -$1.47, with 3.0 analysts recommending between -$1.42 and -$1.58.
